As of 2025-11-04, the Relative Valuation of Regenxbio Inc (RGNX) is (90.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.99 USD, the upside of Regenxbio Inc based on Relative Valuation is -857.4%.
The range of the Relative Valuation is (83.77) - (83.77) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.1x - 24.1x | 24.1x |
| Forward P/E multiples | 24.1x - 32.2x | 28.2x |
| Fair Price | (83.77) - (83.77) | (90.81) |
| Upside | -798.7% - -798.7% | -857.4% |
| Date | P/E |
| 2025-10-31 | -3.67 |
| 2025-10-30 | -3.69 |
| 2025-10-29 | -3.69 |
| 2025-10-28 | -3.79 |
| 2025-10-27 | -3.92 |
| 2025-10-24 | -3.75 |
| 2025-10-23 | -3.62 |
| 2025-10-22 | -3.51 |
| 2025-10-21 | -3.77 |
| 2025-10-20 | -3.64 |
| 2025-10-17 | -3.37 |
| 2025-10-16 | -3.55 |
| 2025-10-15 | -3.54 |
| 2025-10-14 | -3.24 |
| 2025-10-13 | -3.26 |
| 2025-10-10 | -3.14 |
| 2025-10-09 | -3.50 |
| 2025-10-08 | -3.52 |
| 2025-10-07 | -3.02 |
| 2025-10-06 | -3.08 |
| 2025-10-03 | -3.00 |
| 2025-10-02 | -3.04 |
| 2025-10-01 | -2.81 |
| 2025-09-30 | -2.78 |
| 2025-09-29 | -2.83 |
| 2025-09-26 | -2.78 |
| 2025-09-25 | -2.69 |
| 2025-09-24 | -2.74 |
| 2025-09-23 | -2.57 |
| 2025-09-22 | -2.61 |
| 2025-09-19 | -2.56 |
| 2025-09-18 | -2.69 |
| 2025-09-17 | -2.60 |
| 2025-09-16 | -2.66 |
| 2025-09-15 | -2.62 |
| 2025-09-12 | -2.65 |
| 2025-09-11 | -2.73 |
| 2025-09-10 | -2.75 |
| 2025-09-09 | -2.85 |
| 2025-09-08 | -2.73 |
| 2025-09-05 | -2.79 |
| 2025-09-04 | -2.71 |
| 2025-09-03 | -2.84 |
| 2025-09-02 | -2.62 |
| 2025-08-29 | -2.57 |
| 2025-08-28 | -2.59 |
| 2025-08-27 | -2.54 |
| 2025-08-26 | -2.62 |
| 2025-08-25 | -2.58 |
| 2025-08-22 | -2.59 |